Averin Capital Acquisition Corp. reports news centered on its SPAC capital structure, public units and related securities. Recurring developments include initial public offering activity, over-allotment option exercises, Class A ordinary share and redeemable warrant terms, Nasdaq security symbols and other security-structure disclosures.
Company updates also cover shareholder voting matters, governance matters and capital actions typical of a blank-check issuer formed to pursue a business combination.
Averin Capital Acquisition Corp (Nasdaq: ACAAU) said that beginning April 10, 2026 holders of IPO units may elect to separately trade the Company’s Class A ordinary shares and warrants. No fractional warrants will be issued; only whole warrants will trade.
Separated Class A shares will trade as ACAA and warrants as ACAAW; unsplit units remain under ACAAU.
Averin Capital Acquisition Corp (NASDAQ: ACAAU) announced a partial exercise of its IPO over-allotment option on March 5, 2026. The underwriter purchased an additional 3,386,008 units at $10.00 per unit, generating about $33,860,080 in gross proceeds.
After the partial exercise, total units sold rose to 28,386,008 units, producing total gross proceeds of $283,860,080. Each unit contains one Class A ordinary share and one-sixth of a warrant; each whole warrant is exercisable at $11.50. Separate trading is expected under tickers ACAA (shares) and ACAAW (warrants).
Averin Capital Acquisition Corp (NASDAQ: ACAAU) completed a $250,000,000 initial public offering of 25,000,000 units at $10.00 per unit, with trading beginning February 19, 2026. Each unit equals one Class A ordinary share plus one-sixth of a redeemable warrant, exercisable at $11.50 per share.
The company granted a 45-day over-allotment option for 3,750,000 units and placed $2,000,000 in trust. Averin is a blank check company targeting technology and health sector combinations; registration was declared effective by the SEC on February 18, 2026.
Averin Capital Acquisition Corp (NASDAQ:ACAAU) priced a $250,000,000 initial public offering of 25,000,000 units at $10.00 per unit, expected to begin trading on Feb 19, 2026.
Each unit includes one Class A share and one-sixth of a warrant (whole warrant strike $11.50). $10.00 per unit will be deposited into a trust account. The offering is expected to close on Feb 20, 2026 and includes a 45-day option to sell an additional 3,750,000 units. The sponsor is a blank-check company targeting technology and health, led by David A. Berry and Alex Lau; Deutsche Bank is sole book-runner.